News & Media


For press inquiries, contact Charles or Greg.

Smart Brief

CMS postpones national coverage decision for CAR T-cell therapies

The CMS said Friday it would delay a final national coverage determination for chimeric antigen receptor T-cell therapies for cancer treatment such as Novartis' Kymriah and Gilead Sciences' Yescarta. The agency didn't give any reason for the delay in finalizing the proposal, released in February. MedCity News (5/19)

Keep Reading

GAO: CMS should improve transparency for major Medicaid changes

Keep Reading

Satisfaction with commercial health coverage continues to climb

Keep Reading

Senate bill would address surprise billing through arbitration

Keep Reading

Radio Interviews

PCMA President Mark Merritt highlights ways PBMs reduce prescription drug costs for consumers.

KJFF Radio AM (News), St. Louis

KMZU Radio, Kansas City

KLTF Radio AM (News), Minnesota

USA Radio Network (Talk)